Information Library
Results for: Clinical Services - Product Development & Commercialization
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Cancer Treatments and the Search for Value
White Paper — April 2, 2012
Cancer Treatment and the Search for Value In September 2011, The Economist Intelligence Unit surveyed 399 senior executives from the life sciences industry and payer -
Accelerating Success in Oncology
Brochure — March 9, 2012
New Demands to Demonstrate Value Require New Strategy Proof of efficacy is no longer enough to ensure success in oncology. As the cost and complexity -
ASCO 2012 – Accelerating Investigator Success in Oncology Trials
Event — Conference Date(s): June 1 - June 4, 2012
Location: Chicago, IL | McCormick Place
Booth Number: 2062
-
Harish Dave Discusses ASH 2011
Hear from the Experts — December 8, 2011
Harish Dave discusses the American Society of Hematology annual meeting. -
Quintiles Strengthens Late Phase Offerings with Acquisition of Outcome Sciences, Inc.
Press Release — October 19, 2011 – With late phase (Phase IIIB and Phase IV) research becoming increasingly important to multiple healthcare stakeholders, Quintiles has acquired Outcome Sciences, Inc. (Outcome).
-
Quintiles Names New Global Head of Clinical & Data Operations
Press Release — October 6, 2011 – Quintiles announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit.
-
Quintiles Addresses Key Considerations for Successful Biosimilar Development
Press Release — September 29, 2011 – Regulatory and commercial considerations are the primary drivers for successful biosimilar development, according to a new report from Quintiles.
-
An Integrated Approach to Biosimilar Development & Commercialization
White Paper — September 29, 2011
As the market for biosimilar products continues to grow, many biopharmaceutical companies trying to enter the space are struggling to overcome the unique challenges that developing such products presents. -
Quintiles Approach to "Real-World" Research helps Biopharma Customers Drive Competitive Advantage
Press Release — September 19, 2011 –A perfect storm of stakeholder demands, unprecedented data access, new data channels and technologies is driving a dramatic shift in research methodologies among biopharmaceutical companies, according to a new report from Quintiles.
-
A Focus on CNS
Brochure — July 1, 2011
Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process.
